BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the acquisition of Valley Biomedical Products & Services, Inc. located in Winchester, VA.
| WESTBURY, N.Y., June 28, 2021 /PRNewswire/ -- BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the acquisition of Valley Biomedical Products & Services, Inc. located in Winchester, VA.
Founded in 1986, Valley Biomedical provides specialized biological products and services for the biotechnology, research and development, and clinical diagnostics markets. It operates three business units, focused on developing research products and cell culture sera; manufacturing human and animal source blood products to client specifications; and producing non-biological liquid reagents. Valley Biomedical is also an FDA-registered medical device manufacturer, primarily producing in vitro diagnostics (IVDs). “We are delighted that the Valley Biomedical team is joining BioIVT. It is a good match with both companies possessing a similar business approach and work ethic. We have well-trained, experienced staff focused on delivering high quality, consistent products, personalized client service, and excellent technical support. Working together, we will be able to create a broader repertoire of customized solutions to meet individual client needs,” said BioIVT CEO Jeff Gatz. “We had been looking for a partner with similar values and expertise to allow us to continue to grow our business in a smart and thoughtful way. We are confident that our customers will benefit from this new relationship with BioIVT. They will continue to receive the excellent customer service that they expect from Valley Biomedical, while also gaining access to a much wider range of products and services,” said Mario Romano, President of Valley Biomedical. Illustrating how well the companies’ portfolios combine: BioIVT’s cell and gene therapy clients will be able to use Valley Biomedical’s human AB serum for their drug discovery and development work, and its IVD clients will be able to employ Valley Biomedical’s biological matrices as quality control matrices for their manufacturing processes. Conversely, BioIVT’s seven donor centers will provide access to bulk biological matrices that can be processed by Valley Biomedical for cell and gene therapy or IVD applications. BioIVT will continue to operate Valley Biomedical’s Winchester facility and employ all its staff. Financial details about this transaction were not disclosed. About Valley Biomedical About BioIVT BioIVT Contact: Courtney Noah, SVP, Marketing & Client Services, 516-483-1196 Media Contact: Lisa Osborne, Rana Healthcare Solutions, 206-992-5245, lisa@ranahealth.com
SOURCE BioIVT |
View original content to download multimedia:
